The efficacy of drotrecogin alfa depends on severity of illness

Crit Care Med. 2004 Nov;32(11):2347. doi: 10.1097/01.ccm.0000146002.38054.70.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • APACHE*
  • Anti-Infective Agents / therapeutic use*
  • Health Resources / statistics & numerical data
  • Hospital Mortality
  • Humans
  • Protein C / therapeutic use*
  • Recombinant Proteins / therapeutic use*
  • Research Design
  • Sepsis* / drug therapy
  • Sepsis* / mortality
  • Survival Analysis
  • Treatment Outcome

Substances

  • Anti-Infective Agents
  • Protein C
  • Recombinant Proteins
  • drotrecogin alfa activated